Physician profile
John Wesley Johnson
NPI 1972985356
$733.75
in general payments reported to CMS, 2019-2025
14 companies · $144 in 2025
The $144 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $137 · 2020: $13.17 · 2021: $15.71 · 2022: $132 · 2023: $138 · 2024: $155 · 2025: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $437.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $436.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $111.52 | 2022-2025 | Azstarys |
| Merck Sharp & Dohme LLC | $89.39 | 2019-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Sanofi Pasteur INC. | $87.52 | 2024-2025 | |
| Kaleo, INC. | $82.98 | 2019-2024 | Auvi-Q |
| Supernus Pharmaceuticals, INC. | $75.90 | 2023-2024 | Qelbree, Qelbree |
| Sobi, INC | $75.08 | 2022-2023 | |
| Cranial Technologies, INC | $45.24 | 2019-2022 | |
| Alk-Abello, INC | $34.15 | 2025 | Neffy |
| Ironshore Pharmaceuticals INC. | $31.33 | 2019 | |
| Tris Pharma INC | $31.17 | 2019 | |
| Pfizer INC. | $26.69 | 2024 | |
| Integra Lifesciences Corporation | $15.71 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $13.90 | 2025 | Zoryve |
| Adlon Therapeutics L.P. | $13.17 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.